Index Technologies Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Index Technologies Group’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$359K	Buy	+5,990	New	+$377K	0.27%	109

Other funds holding BMRN

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Index Technologies Group's BMRN Position: Q3 2026 in Review

Index Technologies Group opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 5,990 shares worth $359K. The stake represents 0.27% of the portfolio and ranks #109 among its holdings.

434 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

Index Technologies Group held 5,990 shares of BioMarin Pharmaceuticals worth $359K as of Q3 2026.
BioMarin Pharmaceuticals was a new Index Technologies Group position in Q3 2026.
BioMarin Pharmaceuticals made up 0.27% of Index Technologies Group's portfolio in Q3 2026, its #109 holding.
434 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Index Technologies Group's 13F filing for Q3 2026, filed 12 Nov 2026.